Lurbinectedin
RxNorm 2374729
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2374729 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lurbinectedin.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Lurbinectedin
(Atom ID: 12407393)
PTPrescribable
Designated preferred name (PT):
Lurbinectedin
(Atom ID: 12536963)
FNPrescribable
Full form of descriptor (FN):
Lurbinectedin (substance)
(Atom ID: 12536964)
PTPrescribable
Designated preferred name (PT):
Lurbinectedin-containing product
(Atom ID: 12536969)
FNPrescribable
Full form of descriptor (FN):
Product containing lurbinectedin (medicinal product)
(Atom ID: 12537352)
Patient Education
Lurbinectedin Injection
Lurbinectedin injection is used to treat small cell lung cancer (SCLC) that has spread to other parts of the body and did not improve during or after treatment with platinum chemotherapy. Lurbinectedin injection is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.
[Learn More]
* Please review the disclaimer below.